Michael Sandherr
Overview
Explore the profile of Michael Sandherr including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
455
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sandherr M, Stemler J, Schalk E, Hattenhauer T, Hentrich M, Hertenstein B, et al.
Lancet Reg Health Eur
. 2025 Feb;
51:101214.
PMID: 39973942
Febrile Neutropenia is an emergency in the treatment of cancer patients. It requires prompt and evidence-based clinical and antimicrobial management. The implementation of standard operating procedures (SOP) across hospitals and...
2.
Giesen N, Busch E, Schalk E, Beutel G, Ruthrich M, Hentrich M, et al.
Eur J Cancer
. 2023 Jan;
181:102-118.
PMID: 36652889
The novel coronavirus SARS-CoV-2 and the associated infectious disease COVID-19 pose a significant challenge to healthcare systems worldwide. Patients with cancer have been identified as a high-risk population for severe...
3.
Dill V, Wagner C, Keller E, Fernandez-Hernandez F, Shoumariyeh K, Odinius T, et al.
Blood Adv
. 2022 Dec;
7(7):1219-1224.
PMID: 36453650
No abstract available.
4.
Classen A, Sandherr M, Vehreschild J, von Lilienfeld-Toal M
Onkologe (Berl)
. 2022 Mar;
28(4):349-360.
PMID: 35310897
Patients with cancer are at increased risk of infection due to disease-associated or therapy-induced immunosuppression. Taking into account globally increasing antimicrobial resistance rates and negative effects associated with antibiotic treatments,...
5.
Henze L, Buhl C, Sandherr M, Cornely O, Heinz W, Khodamoradi Y, et al.
Ann Hematol
. 2022 Jan;
101(3):491-511.
PMID: 34994811
Clinical reactivations of herpes simplex virus or varicella zoster virus occur frequently among patients with malignancies and manifest particularly as herpes simplex stomatitis in patients with acute leukaemia treated with...
6.
Classen A, Henze L, von Lilienfeld-Toal M, Maschmeyer G, Sandherr M, Graeff L, et al.
Ann Hematol
. 2021 Apr;
100(6):1603-1620.
PMID: 33846857
Hematologic and oncologic patients with chemo- or immunotherapy-related immunosuppression are at substantial risk for bacterial infections and Pneumocystis jirovecii pneumonia (PcP). As bacterial resistances are increasing worldwide and new research...
7.
Giesen N, Sprute R, Ruthrich M, Khodamoradi Y, Mellinghoff S, Beutel G, et al.
Eur J Cancer
. 2021 Mar;
147:154-160.
PMID: 33676266
The worldwide spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the associated infectious coronavirus disease (COVID-19) has posed a unique challenge to medical staff, patients and their...
8.
Giesen N, Sprute R, Ruthrich M, Khodamoradi Y, Mellinghoff S, Beutel G, et al.
Eur J Cancer
. 2020 Oct;
140:86-104.
PMID: 33068941
Since its first detection in China in late 2019 the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the associated infectious disease COVID-19 continue to have a major impact...
9.
Rummel M, Kaiser U, Balser C, Stauch M, Brugger W, Welslau M, et al.
Lancet Oncol
. 2015 Dec;
17(1):57-66.
PMID: 26655425
Background: Fludarabine-based chemoimmunotherapy with rituximab is frequently used in patients with indolent and mantle-cell lymphomas who relapse after alkylating chemotherapy. We aimed to compare the efficacy and safety of rituximab...
10.
Sandherr M, Hentrich M, von Lilienfeld-Toal M, Massenkeil G, Neumann S, Penack O, et al.
Ann Hematol
. 2015 Jul;
94(9):1441-50.
PMID: 26193852
Reactivation of viral infections is common in patients with solid tumour or haematological malignancy. Incidence and severity depend on the extent of cellular immunosuppression. Antiviral prophylaxis may be effective to...